News Enbrel unlikely to face Novartis rival until 2018 Amgen arguing that US patent will last until 2029.
News J&J to "price responsibly", says CEO post Trump meeting Gorsky promises "transparency report" on pricing.
News AbbVie bullish on Humira and near-term pipeline Sales of Humira could peak above $18 billion - CEO
News Roche's Mabthera faces cut-price competition in EU Blockbuster likely to face cheap near-copy for first time.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
